gvtcx

supplier

Eli Lilly & Company Ltd

RG214FA combined from 3 published records

as a supplier

57 recorded awards from 8 buyers , between 10 Aug 2017 and 24 Jun 2025.

awards won
57
exclusive
2%
1 sole-winner awards
median award
£261.9m
largest
£480.4m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

contracts won

contractbuyervalueawarded
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National shared NHS England £261,895,933 24 Jun 2025
NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals shared NHS England £304,504,000 23 Apr 2023
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche shared NHS England £480,429,000 13 Feb 2023
NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche shared NHS England £261,970,000 8 Feb 2023
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual shared NHS England £216,078,796 7 Feb 2022
NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche shared NHS England £1 11 Feb 2021
NHS Framework for the NHS London Region, Branded Medicines - Tranche A shared NHS England £191,062,951 16 Jun 2020
NHS National Branded Proprietary Products (Interim Agreement) - Contracts Finder Award shared NHS England £54,500,000 30 Apr 2020
NHS Midlands and East Branded Medicines - Tranche A shared NHS England £418,787,000 15 Jan 2020
NHS National Agreement for the supply of Teriparatide (Interim Agreement) s Finder Award Notice shared NHS England £7,437,254 24 Sept 2019
NHS South of England Branded Medicines - Tranche A - Contracts Finder Award Notice shared NHS England £188,004,961 31 Jul 2019
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity shared NHS England £251,930,337 4 Jul 2019
NHS Framework agreement for Branded Medicines - North of England - Tranche A shared NHS England £204,551,038 18 Feb 2019
NHS England - Midlands and East Branded Medicines - Tranche B shared NHS England £295,035,882 17 Jan 2019
NHS England Framework Agreement: South of England (Tranche B) shared NHS England £501,400,000 13 Sept 2018
NHS England Framework Agreement - London - Tranche A shared NHS England £211,435,404 14 Aug 2018
NHS Framework Agreement - North of England - Tranche B shared NHS England £521,100,000 13 Feb 2018
NHS Framework Agreement - North of England - Tranche B shared NHS England £521,100,000 8 Jan 2018
NHS England Framework Agreement: Midlands and East (Tranche A) shared NHS England £163,000,000 8 Jan 2018
NHS Framework Agreement for Proprietary Pharmaceuticals - South of England (Tranche A) shared NHS England £232,000,000 10 Aug 2017
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 shared NHS England · 21 Jul 2026
Proprietary Drugs shared eTenderwales · 28 Jul 2025

every contract won by Eli Lilly & Company Ltd →

as published

This page combines 3 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Eli Lilly & Company Ltd · · 45
ELI LILLY & COMPANY LIMITED GB-COH 00284385 · 11
Eli Lilly & Co Limited GB-PPON PTTR-3628-HTTN RG21 4FA 1

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works